REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,421,000 | +101.0% | 51,721 | +31.9% | 0.01% | +66.7% |
| Q4 2018 | $2,200,000 | -63.7% | 39,215 | -47.1% | 0.00% | -25.0% |
| Q3 2018 | $6,062,000 | +537.4% | 74,152 | +172.6% | 0.00% | +300.0% |
| Q2 2018 | $951,000 | +122.7% | 27,197 | +30.5% | 0.00% | 0.0% |
| Q1 2018 | $427,000 | -27.1% | 20,841 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $586,000 | +10.2% | 20,687 | +20.8% | 0.00% | 0.0% |
| Q3 2017 | $532,000 | +9.2% | 17,119 | +11.1% | 0.00% | 0.0% |
| Q2 2017 | $487,000 | +112.7% | 15,407 | +52.3% | 0.00% | – |
| Q1 2017 | $229,000 | +3.6% | 10,116 | 0.0% | 0.00% | – |
| Q4 2016 | $221,000 | -6.4% | 10,116 | +12.8% | 0.00% | – |
| Q3 2016 | $236,000 | +33.3% | 8,968 | 0.0% | 0.00% | – |
| Q2 2016 | $177,000 | – | 8,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |